what is glp-1 analogue Glucagon-like peptide-1 Beyond a singular focus on

Proc Natl Acad Sci U S A (2020) 117(47):2995967

The appetite-suppressing effects of these medications, coupled with their ability to slow gastric emptying and induce a prolonged feeling of fullness, contribute to reduced food intake and subsequent weight reduction

Acta Diabetol

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

This is why terms like Ozempic face have become more common online

She told me a major concern with compounded drugs is the lack of reliability around dose, formulation and source. She also explained that these unapproved products do not come with warning labels that advise their providers of the risks of taking the drug. This raises questions over true informed consent for patients